Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Chief Legal Officer & Corp Sec | September 08, 2026 | September 11, 2026 |
| Covista Inc.ATGE · Entity 3964 | SVP, CLO and Secretary | August 23, 2017 | August 25, 2017 |
| Skyward Specialty Insurance Group, Inc.SKWD · Entity 4400 | Director | May 11, 2026 | May 12, 2026 |
| XPO, Inc.XPO · Entity 3242 | Director | January 04, 2021 | January 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date September 08, 2026 · Filed September 11, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,238 |
Last balance in matching sequence
After 2026-09-08 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2026-09-08 · Sale · Disposed 293 · Balance 9,238 Row 2 · 2026-09-08 · Exercise / conversion · Acquired 6,833 · Balance 16,071 Row 3 · 2026-09-08 · Tax withholding · Disposed 2,769 · Balance 13,302 F1: The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. Row 4 · 2026-09-08 · Sale · Disposed 4,064 · Balance 9,238 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.96 · Expires 2035-05-20 | Direct | 35,658 |
Reported balance
After 2026-09-08 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2026-09-08 · Exercise / conversion · Disposed 6,833 · Balance 35,658 F2: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
F2: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.
Covista Inc.
Report date August 23, 2017 · Filed August 25, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,420 |
Reported balance
After 2017-08-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-08-23 · Grant · Acquired 4,420 · Balance 4,420 F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest in four equal installments beginning on the anniversary of the transaction date. |
| Incentive Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.90 · Expires 2027-08-23 | Direct | 11,796 |
Reported balance
After 2017-08-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-23 · Grant · Acquired 11,796 · Balance 11,796 F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.90 · Expires 2027-08-23 | Direct | 3,129 |
Reported balance
After 2017-08-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-23 · Grant · Acquired 3,129 · Balance 3,129 F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest in four equal installments beginning on the anniversary of the transaction date.
F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations.
Skyward Specialty Insurance Group, Inc.
Report date May 11, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,570 |
Ending reported balance
After 2026-05-11 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-05-11 · Exercise / conversion · Acquired 1,797 · Balance 5,310 F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. Row 2 · 2026-05-11 · Sale · Disposed 100 · Balance 5,210 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Row 3 · 2026-05-11 · Sale · Disposed 140 · Balance 5,070 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Row 4 · 2026-05-11 · Sale · Disposed 500 · Balance 4,570 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. |
| 2025 RSU AwardSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-11 · Exercise / conversion · Disposed 1,797 · Balance 0 F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. F3: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026. F4: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock.
F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4.
F3: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026.
F4: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window.
XPO, Inc.
Report date January 04, 2021 · Filed January 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,604 |
Reported balance
After 2021-01-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-01-04 · Grant · Acquired 1,604 · Balance 1,604 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,392 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 2,392 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F3: The RSUs vested in full on January 4, 2021 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,249 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 3,249 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F4: The RSUs vested in full on January 2, 2020 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,071 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,071 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F5: The RSUs vested in full on January 2, 2019 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,970 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 3,970 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F6: The RSUs vested in full on January 3, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,716 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,716 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F7: The RSUs vested in full on January 1, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock.
F2: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer.
F3: The RSUs vested in full on January 4, 2021 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F4: The RSUs vested in full on January 2, 2020 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F5: The RSUs vested in full on January 2, 2019 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F6: The RSUs vested in full on January 3, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F7: The RSUs vested in full on January 1, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
GXO Logistics, Inc.
Report date May 13, 2025 · Filed May 15, 2025
Section 16 reporting ended · disclosed 2025-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,380 |
Reported balance
After 2025-05-13 transaction · row 1
1 source rowRow 1 · 2025-05-13 · Exercise / conversion · Acquired 3,617 · Balance 12,380 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-13 · Exercise / conversion · Disposed 3,617 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock.
F2: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2024 Filed Mar 11, 2024 19:49 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 16,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001304492-24-000032 · wk-form4_1710186534.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,862 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 1/3 of the RSUs vest on May 22, 2025, with the remaining RSUs vesting in 2 equal annual installments thereafter. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 5,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · derivative · entry 12 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F10 · derivative.exercise_date: The RSUs vested in full on January 1, 2018 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. F10 · derivative.expiration_date: The RSUs vested in full on January 1, 2018 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 8,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · derivative · entry 11 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,730 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F9 · derivative.exercise_date: The RSUs vested in full on January 3, 2018 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. F9 · derivative.expiration_date: The RSUs vested in full on January 3, 2018 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 4,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · derivative · entry 10 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F8 · derivative.exercise_date: The RSUs vested in full on January 2, 2019 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. F8 · derivative.expiration_date: The RSUs vested in full on January 2, 2019 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 7,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · derivative · entry 9 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,145 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F7 · derivative.exercise_date: The RSUs vested in full on January 2, 2020 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. F7 · derivative.expiration_date: The RSUs vested in full on January 2, 2020 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 5,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · derivative · entry 8 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,260 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F6 · derivative.exercise_date: The RSUs vested in full on January 4, 2021 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. F6 · derivative.expiration_date: The RSUs vested in full on January 4, 2021 and were subject to a deferral election. On December 23, 2022, the Compensation Committee of the Board of Directors of GXO terminated the deferral and accelerated the payment of the RSUs to as soon as practicable after January 2, 2024 and not later than January 31, 2024. Pursuant to the terms of the termination of the director deferral, on January 3, 2024 the deferred shares of GXO Common Stock were delivered. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 4,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · derivative · entry 7 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F5 · derivative.exercise_date: The RSUs vested in full on January 3, 2024. F5 · derivative.expiration_date: The RSUs vested in full on January 3, 2024. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | SaleCommon Stock | 900 | $58.70 | $52,827.03 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · nonDerivative · entry 6 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,062 F1 · shares: The sales reported in this Form 4 were automatically effected pursuant to a previously executed selling plan dated December 15, 2022, that is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The shares were sold for tax and estate planning purposes. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $58.67 to $58.75, inclusive. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | SaleCommon Stock | 9,626 | $58.09 | $559,220.54 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · nonDerivative · entry 5 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,962 F1 · shares: The sales reported in this Form 4 were automatically effected pursuant to a previously executed selling plan dated December 15, 2022, that is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The shares were sold for tax and estate planning purposes. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $57.67 to $58.66, inclusive. The reporting person undertakes to provide to GXO Logistics, Inc. ("GXO"), any security holder of GXO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 8,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · nonDerivative · entry 4 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 7,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · nonDerivative · entry 3 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 5,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 4,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:08 UTC | GXO Logistics, Inc. GXO · Entity 3871 | GrantRestricted Stock Units · Derivative | 1,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000002 · wk-form4_1704406109.xml · derivative · entry 13 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,282 Underlying: Common Stock · 1,282 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F11 · derivative.exercise_date: The RSUs shall vest in full on January 2, 2025, subject to the Reporting Person's continued service as a director of GXO. F11 · derivative.expiration_date: The RSUs shall vest in full on January 2, 2025, subject to the Reporting Person's continued service as a director of GXO. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 00:42 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 936 | $32.05 | $30,000.67 |
DisclosureSEC source: 0001209191-23-057315 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,227 F1 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $32.05 to $32.07. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 21:46 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 506 | $33.55 | $16,976.30 |
DisclosureSEC source: 0001209191-23-046387 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,163 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 15:38 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | GrantCommon Stock | 1,734 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-012305 · form4-08162023_030849.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,734 F1 · shares: On August 14, 2023, the reporting person was granted a Restricted Stock Award in the amount of 1,734 shares of common stock. This award will fully vest on August 14, 2024. F1 · price: On August 14, 2023, the reporting person was granted a Restricted Stock Award in the amount of 1,734 shares of common stock. This award will fully vest on August 14, 2024. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 22:12 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 7,235 | $34.72 | $251,168.81 |
DisclosureSEC source: 0001209191-23-038582 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,669 Read SEC document |
| May 18, 2023 Filed May 22, 2023 23:21 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 3,542 | $31.11 | $110,191.62 |
DisclosureSEC source: 0001209191-23-031606 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,904 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 22:12 UTC | GXO Logistics, Inc. GXO · Entity 3871 | SaleCommon Stock | 2,120 | $52.73 | $111,787.60 |
DisclosureSEC source: 0001669943-23-000003 · wf-form4_167407992331598.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sale reported in this Form 4 was automatically effected pursuant to a previously executed selling plan dated December 15, 2022, that is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The shares were sold for tax and estate planning purposes. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:19 UTC | GXO Logistics, Inc. GXO · Entity 3871 | GrantRestricted Stock Units · Derivative | 4,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-23-000001 · wf-form4_167287076543949.xml · derivative · entry 3 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,453 Underlying: Common Stock · 4,453 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F3 · derivative.exercise_date: The RSUs shall vest in full on January 3, 2024, subject to the Reporting Person's continued service as a director of GXO. F3 · derivative.expiration_date: The RSUs shall vest in full on January 3, 2024, subject to the Reporting Person's continued service as a director of GXO. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:19 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-23-000001 · wf-form4_167287076543949.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,120 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2 · derivative.exercise_date: The RSUs vested in full on January 3, 2023. F2 · derivative.expiration_date: The RSUs vested in full on January 3, 2023. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:19 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-23-000001 · wf-form4_167287076543949.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 01:24 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 279 | $35.43 | $9,884.36 |
DisclosureSEC source: 0001209191-22-058993 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,446 Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 22:52 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 146 | $36.98 | $5,399.08 |
DisclosureSEC source: 0001209191-22-057651 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,725 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 00:19 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 920 | $36.90 | $33,951.68 |
DisclosureSEC source: 0001209191-22-056268 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,871 F1 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $36.9026 to $36.97. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 22:31 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 521 | $48.69 | $25,367.49 |
DisclosureSEC source: 0001209191-22-046460 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,791 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 01:31 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 5,680 | $42.87 | $243,518.64 |
DisclosureSEC source: 0001209191-22-033334 · doc4.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,312 F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.69 to $43.14. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 01:31 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,819 | $42.47 | $119,722.93 |
DisclosureSEC source: 0001209191-22-033334 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,992 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:15 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 18,368 | $0.00 Strike: $49.39 | $0.00 |
DisclosureSEC source: 0001209191-22-030497 · doc4.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,368 Underlying: Common Stock · 18,368 shares Expires 2032-05-17 F2 · derivative.exercise_date: 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:15 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 9,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030497 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,811 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:30 UTC | GXO Logistics, Inc. GXO · Entity 3871 | SaleCommon Stock | 3,527 | $80.00 | $282,160.00 |
DisclosureSEC source: 0001104659-22-029444 · tm228256-1_4seq1.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 23:29 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 293 | $55.00 | $16,115.00 |
DisclosureSEC source: 0001209191-22-008588 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,699 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:53 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 3,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001031 · tm221529-7_4seq1.xml · derivative · entry 3 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,527 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F3 · derivative.exercise_price: On August 2, 2021, XPO Logistics, Inc. ("XPO") completed a prorata spinoff distribution ("Distribution") of all of its shares of GXO Common Stock, to the holders of record of XPO common stock, par value $0.001 per share ("XPO Common Stock"), on July 23, 2021. In connection with the Distribution, pursuant to the terms of the Employee Matters Agreement, dated as of August 1, 2021, by and between XPO and GXO, all outstanding equity awards with respect to XPO Common Stock held by the Reporting Person were equitably adjusted and converted into equity awards with respect to GXO Common Stock, with such equitable adjustments determined based on (i) the closing price of a share of XPO Common Stock on the close of trading on July 30, 2021 and (ii) the closing price of a share of GXO Common Stock on August 2, 2021. F4 · derivative.exercise_date: The RSUs vested in full on January 3, 2022. F4 · derivative.expiration_date: The RSUs vested in full on January 3, 2022. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:53 UTC | GXO Logistics, Inc. GXO · Entity 3871 | GrantRestricted Stock Units · Derivative | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001031 · tm221529-7_4seq1.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,120 Underlying: Common Stock · 2,120 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2 · derivative.exercise_date: The RSUs shall vest in full on January 3, 2023, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: The RSUs shall vest in full on January 3, 2023, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:53 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 3,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001031 · tm221529-7_4seq1.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:07 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 131 | $61.45 | $8,049.95 |
DisclosureSEC source: 0001209191-21-065316 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,992 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted January 2021. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 23:33 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 997 | $61.96 | $61,777.21 |
DisclosureSEC source: 0001209191-21-063708 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,123 F1 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $61.9631 to $61.9634. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 22:51 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 445 | $55.31 | $24,612.95 |
DisclosureSEC source: 0001209191-21-052626 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,120 F1 · kind: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units granted July 2019. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 22:03 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 2,301 | $56.11 | $129,109.11 |
DisclosureSEC source: 0001209191-21-052002 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,565 Read SEC document |
| May 24, 2021 Filed May 24, 2021 23:43 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,307 | $48.65 | $63,585.55 |
DisclosureSEC source: 0001209191-21-035530 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,866 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 05, 2021 Filed May 6, 2021 21:42 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 19,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030676 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,173 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 5, 2022 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 05, 2021 Filed May 10, 2021 22:30 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 19,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031397 · doc4a.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,173 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 15, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter. The prior Form 4 incorrectly reported that 25% of the RSUs vest and become exercisable on May 5, 2022, with the remaining RSUs vesting in 3 equal annual installments thereafter. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 23:17 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 948 | $45.04 | $42,697.92 |
DisclosureSEC source: 0001209191-21-012860 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,607 Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 23:20 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 849 | $0.00 Strike: $32.90 | $0.00 |
DisclosureSEC source: 0001209191-21-002814 · doc4.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849 Underlying: Common Stock · 849 shares Expires 2031-01-07 F1 · derivative.exercise_date: The option shares vest and become exercisable in 2 equal annual installments measured from January 7, 2021. Read SEC document |
| January 07, 2021 Filed Jan 14, 2021 23:27 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 0 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003674 · doc4a.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2031-01-07 F2 · derivative.exercise_date: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported. F2 · balance_after: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported. Read SEC document |
| January 07, 2021 Filed Jan 14, 2021 23:27 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003674 · doc4a.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,555 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest in 2 equal annual installments on January 7, 2022 and January 7, 2023. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 02:01 UTC | XPO, Inc. XPO · Entity 3242 | GrantRestricted Stock Unit · Derivative | 1,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001166003-21-000009 · wf-form4_160989844710129.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,604 Underlying: Common Stock, par value $0.001 per share · 1,604 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2 · derivative.exercise_date: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer. F2 · derivative.expiration_date: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 21:30 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 493 | $44.80 | $22,086.65 |
DisclosureSEC source: 0001209191-20-048552 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,706 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted July 2019. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.80 to $44.88. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2020 Filed Jun 4, 2020 23:17 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 1,290 | $55.00 | $70,950.00 |
DisclosureSEC source: 0001209191-20-034561 · doc4.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,199 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units and restricted stock units (the "Bonus RSUs") received in lieu of a cash bonus payment the Recipient was eligible to receive pursuant to the Issuer's Short-Term Incentive Plan for services performed by the Recipient during the fiscal year ended March 31, 2020. The Issuer's Compensation Committee issued the Bonus RSUs in lieu of the cash bonus payment to help conserve the Issuer's cash resources. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.